{"id":"NCT00293540","sponsor":"International Breast Cancer Research Foundation","briefTitle":"Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer","officialTitle":"Phase III Randomized Study of Luteal Phase vs. Follicular Phase Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor-Positive Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2014-02","completion":"2015-03","firstPosted":"2006-02-17","resultsPosted":"2016-06-28","lastUpdate":"2016-07-27"},"enrollment":249,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"PROCEDURE","name":"oophorectomy","otherNames":[]},{"type":"DRUG","name":"Tamoxifen","otherNames":["Nolvadex"]}],"arms":[{"label":"A","type":"ACTIVE_COMPARATOR"},{"label":"B","type":"ACTIVE_COMPARATOR"}],"summary":"This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer survival.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Up to 9 years","effectByArm":[{"arm":"A Mid-luteal Surgery","deltaMin":2.14,"sd":null},{"arm":"B Mid-follicular Surgery","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":21,"countries":["United States","Bangladesh","China","India","Indonesia","Malaysia","Morocco","Nigeria","Philippines","Vietnam"]},"refs":{"pmids":["27107325"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":115},"commonTop":[]}}